Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Zeitlinger

Showing results (291-300 of 352) with videos related to

Pageof 36
Sort By:
The Journal of Antimicrobial Chemotherapy|December 9, 2023
Effect of albumin substitution on pharmacokinetics of piperacillin/tazobactam in patients with severe burn injury admitted to the ICUBeatrix Wulkersdorfer, Felix Bergmann, Lisa Amann, et al.
The Journal of Antimicrobial Chemotherapy|August 15, 2021
Meropenem concentrations in brain tissue of neurointensive care patients exceed CSF levelsArthur Hosmann, Lavinia Ritscher, Heinz Burgmann, et al.
International Journal of Antimicrobial Agents|April 16, 2025
Cerebrospinal fluid concentrations of ceftaroline and ceftazidime/avibactam in healthy volunteers: Pharmacokinetics and probability of target attainmentMichael Wölfl-Duchek, Wisse van Os, Valentin Al Jalali, et al.
Cell Death & Disease|October 27, 2017
The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosisKatharina Staufer, Mirko Dengler, Heidemarie Huber, et al.
The Journal of Antimicrobial Chemotherapy|August 30, 2022
Comparison of pharmacokinetics and stability of generics of cefepime, linezolid and piperacillin/tazobactam with their respective originator drugs: an intravenous bioequivalence study in healthy volunteersFelix Bergmann, Beatrix Wulkersdorfer, Zoe Oesterreicher, et al.
The Lancet. Infectious Diseases|October 15, 2020
Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trialRichard G Wunderink, Yuko Matsunaga, Mari Ariyasu, et al.
Anaesthesia, Critical Care & Pain Medicine|April 25, 2025
Efficacy of solnatide to treat pulmonary permeability edema in SARS-CoV-2 positive patients with moderate to severe ARDS: A randomized controlled pilot-trialKatharina Krenn, Felix Kraft, Matthias Urban, et al.
Plos One|May 14, 2016
Microdialysis Assessment of Cerebral Perfusion during Cardiac Arrest, Extracorporeal Life Support and Cardiopulmonary Resuscitation in Rats - A Pilot TrialAndreas Schober, Alexandra M Warenits, Christoph Testori, et al.
EJNMMI Research|December 14, 2019
Assessment of brain delivery of a model ABCB1/ABCG2 substrate in patients with non-contrast-enhancing brain tumors with positron emission tomographyBeatrix Wulkersdorfer, Martin Bauer, Rudolf Karch, et al.
Haematologica|April 19, 2012
Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical responseUlrich Jäger, Michael Fridrik, Markus Zeitlinger, et al.
Pageof 36

Showing results (291-300 of 352) with videos related to

Sort By:
Pageof 36
The Journal of Antimicrobial Chemotherapy|December 9, 2023
Effect of albumin substitution on pharmacokinetics of piperacillin/tazobactam in patients with severe burn injury admitted to the ICUBeatrix Wulkersdorfer, Felix Bergmann, Lisa Amann, et al.
The Journal of Antimicrobial Chemotherapy|August 15, 2021
Meropenem concentrations in brain tissue of neurointensive care patients exceed CSF levelsArthur Hosmann, Lavinia Ritscher, Heinz Burgmann, et al.
International Journal of Antimicrobial Agents|April 16, 2025
Cerebrospinal fluid concentrations of ceftaroline and ceftazidime/avibactam in healthy volunteers: Pharmacokinetics and probability of target attainmentMichael Wölfl-Duchek, Wisse van Os, Valentin Al Jalali, et al.
Cell Death & Disease|October 27, 2017
The non-invasive serum biomarker soluble Axl accurately detects advanced liver fibrosis and cirrhosisKatharina Staufer, Mirko Dengler, Heidemarie Huber, et al.
The Journal of Antimicrobial Chemotherapy|August 30, 2022
Comparison of pharmacokinetics and stability of generics of cefepime, linezolid and piperacillin/tazobactam with their respective originator drugs: an intravenous bioequivalence study in healthy volunteersFelix Bergmann, Beatrix Wulkersdorfer, Zoe Oesterreicher, et al.
The Lancet. Infectious Diseases|October 15, 2020
Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trialRichard G Wunderink, Yuko Matsunaga, Mari Ariyasu, et al.
Anaesthesia, Critical Care & Pain Medicine|April 25, 2025
Efficacy of solnatide to treat pulmonary permeability edema in SARS-CoV-2 positive patients with moderate to severe ARDS: A randomized controlled pilot-trialKatharina Krenn, Felix Kraft, Matthias Urban, et al.
Plos One|May 14, 2016
Microdialysis Assessment of Cerebral Perfusion during Cardiac Arrest, Extracorporeal Life Support and Cardiopulmonary Resuscitation in Rats - A Pilot TrialAndreas Schober, Alexandra M Warenits, Christoph Testori, et al.
EJNMMI Research|December 14, 2019
Assessment of brain delivery of a model ABCB1/ABCG2 substrate in patients with non-contrast-enhancing brain tumors with positron emission tomographyBeatrix Wulkersdorfer, Martin Bauer, Rudolf Karch, et al.
Haematologica|April 19, 2012
Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical responseUlrich Jäger, Michael Fridrik, Markus Zeitlinger, et al.
Pageof 36